Calendar · pharmadog

Sign In Subscribe

Week of Mar 16, 2026

50

Mar 17, 2026grant167d agoUNIVERSITY OF WASHINGTON — Adaptive Neural control of Respiration in DrosophilaUniversity of Washington

NS grant. $122,769. PI: Yichen Luo

full page →nih reporter ↗

Mar 17, 2026grant167d agoHANNOVER MEDICAL SCHOOL — The growth factor meteorin-like and its receptor KIT in heart failure

HL grant. $4,750. PI: Lillian Hyde

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF CONNECTICUT STORRS — Implantable, Degradable Drug Delivery Devices for Non-Opioid Post-Surgical Pa...

EB grant. $39,349. PI: Kelly Anne Burke

full page →nih reporter ↗

Mar 17, 2026grant167d agoBRIGHAM AND WOMEN'S HOSPITAL — SocialBit2: High-fidelity Mobile Sensing of Social Connection after StrokeBrigham and Women's Hospital

NS grant. $716,816. PI: Amar Dhand

full page →nih reporter ↗

Mar 17, 2026grant167d agoYALE UNIVERSITY — Plasma-derived astrocyte-enriched exosomes as a platform for ALS patient stra...

NS grant. $461,197. PI: David Pitt

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Systemic Lipid Metabolism After Aneurysmal Subarachnoid Hemorrhage (SLIM-SAH)

NS grant. $632,144. PI: Aaron Mark Gusdon

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Transposon-mediated genetic manipulation of OPCs to study their role in synap...

NS grant. $471,861. PI: David Christopher Martinelli

full page →nih reporter ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

full page →MYCOPHENOLATE MOFETIL →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 18, 2026approval166d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoXTORO (FINAFLOXACIN) — FDA approval

Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoXTORO (FINAFLOXACIN) — FDA approval

Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoBUSULFAN — FDA approvalWoodward Pharma Services LLC

Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoPAROXETINE MESYLATE — FDA approvalLegacy Pharma Solutions

Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: ACCORD HLTHCARE. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoLISDEXAMFETAMINE DIMESYLATE — FDA approvalLISDEXAMFETAMINE DIMESYLATE

Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL

full page →LISDEXAMFETAMINE DIMESYLATE →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

full page →ATROPINE SULFATE →fda approvals ↗

Mar 18, 2026approval166d agoTRANEXAMIC ACID — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: DR REDDYS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVONJO (PACRITINIB CITRATE) — FDA approvalpacritinib

Sponsor: SOBI. Form: CAPSULE. Route: ORAL

full page →pacritinib →fda approvals ↗

Mar 18, 2026approval166d agoCLINDAMYCIN PHOSPHATE — FDA approvalCLEOCIN

Sponsor: AUROBINDO PHARMA LTD. Form: GEL. Route: TOPICAL

full page →CLEOCIN →fda approvals ↗

Mar 18, 2026approval166d agoCABERGOLINE — FDA approvalCABERGOLINE

Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

full page →CABERGOLINE →fda approvals ↗

Mar 18, 2026approval166d agoFEXOFENADINE HYDROCHLORIDE ALLERGY (FEXOFENADINE HYDROCHLORIDE) — FDA approvalPERRIGO Co plc

Sponsor: UNIQUE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: MSN. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoBAL (DIMERCAPROL) — FDA approvalAkorn Operating Company LLC (Inactive)

Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGPODER (VIGABATRIN) — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: PYROS PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoMETOPROLOL TARTRATE — FDA approvalIpca Pharmaceuticals Inc

Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoMETOPROLOL TARTRATE — FDA approvalIpca Pharmaceuticals Inc

Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoMETOPROLOL TARTRATE — FDA approvalIpca Pharmaceuticals Inc

Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: DEXCEL. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: ALKEM LABS LTD. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGADRONE (VIGABATRIN) — FDA approvalVIGABATRIN

Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoDESOGESTREL AND ETHINYL ESTRADIOL (DESOGESTREL) — FDA approvalDESOGESTREL AND ETHINYL ESTRADIOL

Sponsor: ANNORA PHARMA. Form: TABLET. Route: ORAL-28

full page →DESOGESTREL AND ETHINYL ESTRADIOL →fda approvals ↗

Mar 18, 2026approval166d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

full page →risankizumab →fda approvals ↗

Mar 18, 2026approval166d agoPROSCAR (FINASTERIDE) — FDA approvalPROSCAR

Sponsor: ORGANON. Form: TABLET. Route: ORAL

full page →PROSCAR →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoPOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approvalpolatuzumab vedotin

Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS

full page →polatuzumab vedotin →fda approvals ↗

page 161 of 300